keep an eye on this (help me I am running out of eyes!) an AR degrader really aims at destroying AR receptors, the idea is that when a second generation arsi is no longer working (Enza, Daro,…) you still have the option to use this new drug for metastatic prostate cancer
UBX-103: potentially first in class A... - Advanced Prostate...
UBX-103: potentially first in class AR degrader
![Maxone73 profile image](https://images.hu-production.be/avatars/cc6cfcd066d747309f3dc14136bd6475_small@2x_100x100.jpg)
Written by
![Maxone73 profile image](https://images.hu-production.be/avatars/cc6cfcd066d747309f3dc14136bd6475_small@2x_100x100.jpg)
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not what you're looking for?
You may also like...
Dangers of AR degradation through ARV-110 etc?
on the thread on loss and revival of androgen receptor signaling through the over repression of the...
Novel AR-Targeted Therapies for mHSPC: Which One to Choose
herapies-for-metastatic-hormone-sensitive-prostate-cancer-which-one-to-choose
A comment stood out...
PROTAC -- new class of drug - first trial for prostate cancer
mid-2019, will include 28–36 men with metastatic prostate cancer and will last around 9 months,...
AR-V7 - CTC's - Risk of Death
benefit-for-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc.html
Can melatonin control AR amplification and therefore help mCRPC drugs work better and longer?
in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-Resistant...